Ballicules.com

Ropinirole

REQUIP

What it isNon-ergot D2/D3 dopamine agonist; Parkinson disease and restless legs syndrome.

Why this oneUnlike pramipexole, it is cleared hepatically through CYP1A2, making renal impairment less limiting.

What limits itAsk directly about gambling, shopping, hypersexuality, and sudden sleep; hallucinations and orthostasis also limit use.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Parkinson's diseaseAdults0.25 mg TIDtitrate to response24 mg/day (8 mg TID); ESRD on hemodialysis 18 mg/day
Restless legs syndromeAdults0.25 mg QD (1–3 h before bedtime)titrate to response4 mg/day; ESRD on hemodialysis 3 mg/day

Titration PD: increase at weekly intervals. RLS: increase after 2 days, then at weekly intervals.

Renal Moderate (CrCl 30–50): no adjustment. ESRD on hemodialysis: max 18 mg/day (PD), 3 mg/day (RLS); no post-dialysis supplement. Severe without dialysis: not studied.

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy No adequate human data; animal data show fetal harm (teratogenicity, embryolethality).

Lactation Undefined

NO BOXED WARNINGS

Principal riskImpulse-control disorders and sudden sleep onset

Cost, est. cash$10–$500/month

Generic entry2008

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryC

Defining liabilityOrthostasis, hallucinations, dyskinesia and impulse-control symptoms; abrupt withdrawal can be hazardous.

Mechanism of action: Ropinirole ballicule

Ropinirole ballicule: receptor binding, kinetics and half-life diagram

Open Ropinirole in the interactive console ↗

Memory aids: mascots and interaction avatars

Ropinirole REQUIP mascot mnemonic cartoon
“Rope in a roll (to) Re-equip”
restless legs → treatment for RLS
Ropinirole CYP1A2 substrate avatar
CYP1A2 substrate

Open Ropinirole in the interactive console ↗